Learn More
ATCC Pseudomonas aeruginosa; Strain PGO2354
Supplier: ATCC BAA2111
Pseudomonas aeruginosa strain PGO2354 was collected from a sputum sample of a cystic fibrosis patient during a Phase III clinical trial that tested the effectiveness of aerosolized Tobi (Tobramycin). This whole-genome sequenced strain is propagated aerobically in trypticase soy medium and is used for drug development research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.